Last 12 months
Inside the activity.
7 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 2 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 5 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 26, 2019 Filed Jun 10, 2019 17:23 UTC Amendment |
Cohen ScotDirector
|
ConversionCommon Stock | 1,900,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-19-000679 · form4a-06102019_100632.xml · nonDerivative · entry 7 Cohen Scot · CIK 0001558913 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By V3 Capital Partners LLC Disclosed balance after: 80,125,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each share of Series B Convertible Preferred Stock ("Series B Preferred") was convertible into that number of shares of the Registrant's common stock equal to the stated value, $4 per share, divided by the conversion price of $0.25 per share. Read SEC document |
| April 26, 2019 Filed Jun 10, 2019 17:23 UTC Amendment |
Cohen ScotDirector
|
ConversionCommon Stock | 200,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-19-000679 · form4a-06102019_100632.xml · nonDerivative · entry 6 Cohen Scot · CIK 0001558913 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by IRA Disclosed balance after: 200,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each share of Series B Convertible Preferred Stock ("Series B Preferred") was convertible into that number of shares of the Registrant's common stock equal to the stated value, $4 per share, divided by the conversion price of $0.25 per share. Read SEC document |
| April 26, 2019 Filed Jun 10, 2019 17:23 UTC Amendment |
Cohen ScotDirector
|
ConversionCommon Stock | 16,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-19-000679 · form4a-06102019_100632.xml · nonDerivative · entry 5 Cohen Scot · CIK 0001558913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,609,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Each share of Series D Convertible Preferred Stock ("Series D Preferred") was convertible into that number of shares of the Registrant's common stock equal to the stated value, $100 per share, divided by the conversion price of $0.025 per share. Read SEC document |
| April 26, 2019 Filed Jun 10, 2019 17:23 UTC Amendment |
Cohen ScotDirector
|
ConversionCommon Stock | 60,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-19-000679 · form4a-06102019_100632.xml · nonDerivative · entry 4 Cohen Scot · CIK 0001558913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,609,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each share of Series B Convertible Preferred Stock ("Series B Preferred") was convertible into that number of shares of the Registrant's common stock equal to the stated value, $4 per share, divided by the conversion price of $0.25 per share. Read SEC document |
| April 26, 2019 Filed Jun 10, 2019 17:23 UTC Amendment |
Cohen ScotDirector
|
GrantCommon Stock | 73,341,261 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-19-000679 · form4a-06102019_100632.xml · nonDerivative · entry 3 Cohen Scot · CIK 0001558913 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By V3 Capital Partners LLC Disclosed balance after: 78,225,152 F2 · price: Shares issued to the Reporting Person as compensation for advisory services rendered by the Reporting Person in connection with Exchange. Read SEC document |
| April 26, 2019 Filed Jun 10, 2019 17:23 UTC Amendment |
Cohen ScotDirector
|
GrantCommon Stock | 73,341,261 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-19-000679 · form4a-06102019_100632.xml · nonDerivative · entry 2 Cohen Scot · CIK 0001558913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,549,439 F2 · price: Shares issued to the Reporting Person as compensation for advisory services rendered by the Reporting Person in connection with Exchange. Read SEC document |
| April 26, 2019 Filed Jun 10, 2019 17:23 UTC Amendment |
Cohen ScotDirector
|
GrantCommon Stock | 28,208,178 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-19-000679 · form4a-06102019_100632.xml · nonDerivative · entry 1 Cohen Scot · CIK 0001558913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,208,178 F1 · price: Securities received by the Reporting Person in exchange for 200,000 membership units of Charlie's Chalk Dust, LLC ("CCD") owned by the Reporting Person in connection with exchange of all outstanding membership units of CCD for securities of the Registrant, consisting of shares of the Registrant's common stock, Series A Convertible Preferred Stock ("Series A Preferred"), and warrants to purchase shares of the Registrant's common stock (the "Exchange"). Read SEC document |
| July 05, 2018 Filed Jul 7, 2018 01:57 UTC |
Sherman Kevin CharlesDirector
|
GrantStock Option · Derivative | 35,971,988 | $0.00 Strike: $0.02 | $0.00 |
DisclosureSEC source: 0001415889-18-001092 · form4-07062018_060718.xml · derivative · entry 3 Sherman Kevin Charles · CIK 0001483052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,971,988 Underlying: Common Stock · 35,971,988 shares Expires 2028-01-30 Read SEC document |
| July 05, 2018 Filed Jul 7, 2018 01:57 UTC |
Sherman Kevin CharlesDirector
|
GrantStock Option · Derivative | 10,238,012 | Not disclosed Strike: $0.03 | Not disclosed |
DisclosureSEC source: 0001415889-18-001092 · form4-07062018_060718.xml · derivative · entry 2 Sherman Kevin Charles · CIK 0001483052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,238,012 Underlying: Common Stock · 10,238,012 shares Expires 2023-01-30 F1 · kind: The reported transaction involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. F1 · price: The reported transaction involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. Read SEC document |
| July 05, 2018 Filed Jul 7, 2018 01:57 UTC |
Sherman Kevin CharlesDirector
|
Disposition to issuerStock Option · Derivative | 10,238,012 | Not disclosed Strike: $0.07 | Not disclosed |
DisclosureSEC source: 0001415889-18-001092 · form4-07062018_060718.xml · derivative · entry 1 Sherman Kevin Charles · CIK 0001483052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: Not disclosed Underlying: Common Stock · 10,238,012 shares Expires 2022-09-29 F1 · kind: The reported transaction involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. F1 · price: The reported transaction involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. F1 · derivative.expiration_date: The reported transaction involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. Read SEC document |
| July 05, 2018 Filed Jul 7, 2018 01:55 UTC |
Cohen ScotDirector
|
GrantStock Option · Derivative | 7,114,826 | $0.00 Strike: $0.02 | $0.00 |
DisclosureSEC source: 0001415889-18-001091 · form4-07062018_060741.xml · derivative · entry 1 Cohen Scot · CIK 0001558913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,114,826 Underlying: Common Stock · 7,114,826 shares Expires 2028-01-30 Read SEC document |
| July 05, 2018 Filed Jul 7, 2018 01:54 UTC |
VAN BOERUM ROBERTCEO AND CFO
|
GrantStock Option · Derivative | 3,172,294 | $0.00 Strike: $0.02 | $0.00 |
DisclosureSEC source: 0001415889-18-001090 · form4-07062018_060756.xml · derivative · entry 3 VAN BOERUM ROBERT · CIK 0001655832 · CEO AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,172,294 Underlying: Common Stock · 3,172,294 shares Expires 2028-01-30 Read SEC document |
| July 05, 2018 Filed Jul 7, 2018 01:54 UTC |
VAN BOERUM ROBERTCEO AND CFO
|
GrantStock Option · Derivative | 3,937,706 | Not disclosed Strike: $0.03 | Not disclosed |
DisclosureSEC source: 0001415889-18-001090 · form4-07062018_060756.xml · derivative · entry 2 VAN BOERUM ROBERT · CIK 0001655832 · CEO AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,937,706 Underlying: Common Stock · 3,937,706 shares Expires 2023-01-30 F1 · kind: The reported transaction involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. F1 · price: The reported transaction involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. F1 · derivative.expiration_date: The reported transaction involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. Read SEC document |
| July 05, 2018 Filed Jul 7, 2018 01:54 UTC |
VAN BOERUM ROBERTCEO AND CFO
|
Disposition to issuerStock Option · Derivative | 3,937,706 | Not disclosed Strike: $0.07 | Not disclosed |
DisclosureSEC source: 0001415889-18-001090 · form4-07062018_060756.xml · derivative · entry 1 VAN BOERUM ROBERT · CIK 0001655832 · CEO AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,937,706 shares Expires 2022-09-29 F1 · kind: The reported transaction involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. F1 · price: The reported transaction involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. F1 · derivative.expiration_date: The reported transaction involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. Read SEC document |
| July 05, 2018 Filed Jul 7, 2018 01:50 UTC |
Greco James JDirector
|
GrantStock Option · Derivative | 12,644,921 | $0.00 Strike: $0.02 | $0.00 |
DisclosureSEC source: 0001415889-18-001089 · form4-07062018_060734.xml · derivative · entry 3 Greco James J · CIK 0001697306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,644,921 Underlying: Common Stock · 12,644,921 shares Expires 2028-01-30 Read SEC document |
| July 05, 2018 Filed Jul 7, 2018 01:50 UTC |
Greco James JDirector
|
GrantStock Option · Derivative | 1,575,079 | Not disclosed Strike: $0.03 | Not disclosed |
DisclosureSEC source: 0001415889-18-001089 · form4-07062018_060734.xml · derivative · entry 2 Greco James J · CIK 0001697306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,575,079 Underlying: Common Stock · 1,575,079 shares Expires 2023-01-30 F1 · kind: The reported transaction involved (i) the forfeiture of 14,175,710 outstanding options, and (ii) the modification of 1,575,079 outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. F1 · price: The reported transaction involved (i) the forfeiture of 14,175,710 outstanding options, and (ii) the modification of 1,575,079 outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. F1 · derivative.expiration_date: The reported transaction involved (i) the forfeiture of 14,175,710 outstanding options, and (ii) the modification of 1,575,079 outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. Read SEC document |
| July 05, 2018 Filed Jul 7, 2018 01:50 UTC |
Greco James JDirector
|
Disposition to issuerStock Option · Derivative | 15,750,789 | Not disclosed Strike: $0.07 | Not disclosed |
DisclosureSEC source: 0001415889-18-001089 · form4-07062018_060734.xml · derivative · entry 1 Greco James J · CIK 0001697306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,750,789 shares Expires 2022-04-13 F1 · kind: The reported transaction involved (i) the forfeiture of 14,175,710 outstanding options, and (ii) the modification of 1,575,079 outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. F1 · price: The reported transaction involved (i) the forfeiture of 14,175,710 outstanding options, and (ii) the modification of 1,575,079 outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. F1 · derivative.expiration_date: The reported transaction involved (i) the forfeiture of 14,175,710 outstanding options, and (ii) the modification of 1,575,079 outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. Read SEC document |
| July 05, 2018 Filed Feb 13, 2019 23:01 UTC |
Greco James JDirector
|
GrantCommon Stock | 5,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-19-000160 · form5-02132019_030248.xml · nonDerivative · entry 1 Greco James J · CIK 0001697306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000,000 F1 · price: The shares reported herein were issued to the Reporting Person in lieu of cash as compensation for services rendered by the Reporting Person to the Issuer from April 2017 to September 2017 in his capacity as Chief Executive Officer. Read SEC document |
| December 01, 2002 Filed Dec 5, 2022 21:13 UTC |
Stump RyanChief Operating Officer
|
PurchaseCommon Stock | 96,933 | $0.18 | $17,254.07 |
DisclosureSEC source: 0001567619-22-021270 · doc1.xml · nonDerivative · entry 1 Stump Ryan · CIK 0001775621 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 498,901 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.